Although Shewanella is usually considered an environmental genus, different clinical infections have appeared in recent years (4, 7). Treatment of such infections is difficult due to the lack of knowledge concerning the natural antimicrobial resistance as well as the recommended antibiotic treatment of their infections (11). The aim of our study was to investigate the antimicrobial resistance mechanisms acquired by this genus in the nosocomial environment.
All isolates identified as Shewanella spp. (n = 10) by the use of standard biochemical tests were collected in a public hospital of Argentina during 2005 and 2006. In Argentina, the relative frequency of isolates positively identified as harboring Shewanella spp. among infections by nonfermentative Gram-negative bacilli (NFGNB), excluding the important pathogens Acinetobacter baumannii and Pseudomonas aeruginosa, is only 2.5% of the total number of isolates. Amplification and sequencing of the 16S rRNA gene was used to identify the isolates (4, 12). Three isolates were identified as Shewanella putrefaciens and seven as Shewanella algae (Table 1).
TABLE 1.
Isolateb | Yr | Source | intI1c | intI2 | Variable region of class 1 integrons | Variable region of class 2 integrons | sul1 | sul2 | sul3 | blaOXA-48-like gene(s) | MICd (μg/ml) |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
MEM | IPM | |||||||||||
Sp117 | 2005 | Otic secretion | + | − | NGCe | + | + | − | + | 4 | 1 | |
Sp95 | 2005 | Ocular secretion | + | − | NGC | + | + | − | + | 0.25 | 0.5 | |
Sp31 | 2005 | Soft tissue | + | − | NGC | − | − | − | + | 0.125 | 0.25 | |
Sa9 | 2006 | Blood culture | + | + | dfrA1 | dfrA1-sat2 | + | + | − | − | 0.125 | 2 |
Sa78 | 2005 | Soft tissue | − | − | + | − | − | 0.25 | 4 | |||
Sa74 | 2006 | Otic secretion | + | + | dfrA1-aadA1 | NGCe | + | + | − | − | 0.0094 | 4 |
Sa10 | 2006 | Leg ulcer | + | + | dfrA1-aadA1 | dfrA1 | + | + | − | − | 1 | 8 |
Sa82 | 2006 | Soft tissue | + | + | dfrA1 | NGC | + | + | − | 0.38 | 0.25 | |
Sa392 | 2006 | Leg ulcer | + | + | dfrA1 | NGC | + | + | − | − | 1 | 4 |
Sa2 | 2006 | Otic secretion | + | + | dfrA1-aadA1 | dfrA1-sat2-aadA1-orfX | + | − | − | − | 0.032 | 0.25 |
The gene cassette arrays in the variable region of class 1 and 2 integrons, the presence of sul genes, the presence of blaOXA-48-like genes, and the meropenem and imipenem MICs, as well as the sources of the samples, are shown.
Isolates of the study: Sp for Shewanella putrefaciens (n = 3) and Sa for Shewanella algae (n = 7).
− and +, negative and positive, respectively, for the presence of intI1, intI2, sul1, sul2, sul3, or blaOXA-48-like genes by PCR with specific primers.
Determinations of meropenem (MEM) and imipenem (IPM) MICs were performed according to CLSI recommendations (3).
NGC, negative for the amplification of gene cassettes.
PCR amplifications using total DNA were performed according to the instructions of the manufacturer (Promega) by the use of specific primers for evaluation of the presence of antimicrobial resistance determinants associated with horizontal gene transfer (most of them usually found in our Gram-negative bacterial isolates): (i) integron integrase genes (intI1, intI2, and intI3) (6, 10); (ii) 13 β-lactamase-like genes, namely, the blaOXA-58, blaOXA-48, blaTEM-1, blaCTX-M-2, blaSHV-like, blaSCO-1, blaPER-2, blaGES-like, blaVEB-like, blaIMP-like, blaVIM-like, blaSPM-1, and blaOXA-23 genes (5, 6, 9); and (iii) sul1, sul2, and sul3 genes (1).
We found the type 1 integrase gene in 9 isolates, while the type 2 integrase gene was found in 6 isolates (Table 1). In order to identify the inserted gene cassettes within the variable region of integrons, PCR cartography and sequencing were performed as previously described (6, 10).
Concerning the variable region of class 1 integrons (vr-1), we found the presence of the dfrA1 gene cassette in isolates Sa9, Sa82, and Sa392 and the dfrA1-aadA1 array in isolates Sa74, Sa10, and Sa2 (Table 1). We were unable to identify gene cassettes within the vr-1 for three isolates (Sp117, Sp95, and Sp31). Concerning class 2 integrons, only the variable region of Sa2 harboring dfrA1-sat2-aadA1-orfX-ybfA-ybfB-ybgA, Sa9 harboring dfrA1-sat2, and Sa10 harboring the dfrA1 gene cassette could be identified (Table 1).
When we investigated the presence of 13 β-lactamase genes, positive amplification was obtained for the 3 isolates of S. putrefaciens (Table 1) by the use of primers for the amplification of the carbapenemase blaOXA-48 gene previously found harbored in a transposon of a Klebsiella pneumoniae isolate from France (9). Sequence analysis revealed 99% identity over a 690-bp length with this gene, 83% identity with the sequence of blaOXA-54 previously described as present in S. oneidensis and suggested as the progenitor of the blaOXA-48 (8), and 78% identity with the sequence of a chromosome-borne blaOXA gene that we have identified in S. putrefaciens CN-32 (CP000681.1) by the use of BLAST software (version 2.0). The meropenem (MEM) and imipenem (IMP) MICs were determined according to CLSI guidelines (3). As was shown in Table 1, no clear contribution of this gene to carbapenem resistances could be established.
Since there is no information about the occurrence of plasmids in Shewanella spp., we performed plasmid extraction using a QIAprep Spin Miniprep kit (Qiagen) to see whether our isolates contained plasmids. We found that plasmids were present in 2 out of 10 isolates (Sa2 and Sp95). We performed PCRs for commonly incompatible groups (IncP, IncW, and IncA/C) found in our bacterial population (reference 2 and data not shown) as well as plasmid extraction followed by Escherichia coli transformation and selection with the corresponding antibiotics, but all experiments gave negative results.
We found not only high levels of dispersion of genetic elements usually associated with horizontal gene transfer for both species but also distinctive epidemiology characteristics, since S. putrefasciens isolates possess the blaOXA-48 gene and class 1 integrons, while S. algae isolates possess class 1 and 2 integrons with different arrays of cassettes in the two species (Table 1).
Given that Shewanella is well known as an environmental genus and that almost all isolates from our study harbored integrons and other relevant determinants of resistance (such as the carbapenemase blaOXA-48) usually associated with horizontal gene transfer, species of this genus could be considered to represent not only a potential reservoir but also a vector of antimicrobial resistance mechanisms in hospital settings and the environment, with transmission occurring in both directions.
Nucleotide sequence accession number.
The partial sequence of the blaOXA-48 gene has been submitted to GenBank and assigned accession no. HM755942.
Acknowledgments
M.S.R. and D.C. are members of the Carrera del Investigador Científico, CONICET-Argentina.
The study was supported by a grant from BID/OC ANPCyT 0690 to D.C. and a grant from UBACyT B080 to C.V., Buenos Aires, Argentina.
Footnotes
Published ahead of print on 2 August 2010.
REFERENCES
- 1.Antunes, P., J. Machado, J. C. Sousa, and L. Peixe. 2005. Dissemination of sulfonamide resistance genes (sul1, sul2, and sul3) in Portuguese Salmonella enterica strains and relation with integrons. Antimicrob. Agents Chemother. 49:836-839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Carattoli, A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53:2227-2238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing—17th informational supplement. M100-S17. CLSI, Wayne, PA.
- 4.Holt, H. M., B. Gahrn-Hansen, and B. Bruun. 2005. Shewanella algae and Shewanella putrefaciens: clinical and microbiological characteristics. Clin. Microbiol. Infect. 11:347-352. [DOI] [PubMed] [Google Scholar]
- 5.Merkier, A. K., and D. Centrón. 2006. blaOXA-51 type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int. J. Antimicrob. Agents 28:110-113. [DOI] [PubMed] [Google Scholar]
- 6.Orman, B. E., S. A. Pineiro, S. Arduino, M. Galas, R. Melano, M. I. Caffer, D. O. Sordelli, and D. Centrón. 2002. Evolution of multiresistance in nontyphoid salmonella serovars from 1984 to 1998 in Argentina. Antimicrob. Agents Chemother. 46:3963-3970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Pagani, L., A. Lang, C. Vedovelli, O. Moling, G. Rimenti, R. Pristera, and P. Mian. 2003. Soft tissue infection and bacteremia caused by Shewanella putrefaciens. J. Clin. Microbiol. 41:2240-2241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Poirel, L., C. Heritier, and P. Nordmann. 2004. Chromosome-encoded ambler class D beta-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase. Antimicrob. Agents Chemother. 48:348-351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Poirel, L., C. Heritier, V. Tolun, and P. Nordmann. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ramírez, M. S., C. Quiroga, and D. Centrón. 2005. Novel rearrangement of a class 2 integron in two non-epidemiologically related isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:5179-5181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Vay, C. A., M. N. Almuzara, C. H. Rodriguez, M. L. Pugliese, F. Lorenzo Barba, J. C. Mattera, and A. M. Famiglietti. 2005. In vitro activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp. Rev. Argent. Microbiol. 37:34-45. [PubMed] [Google Scholar]
- 12.Weisburg, W. G., S. M. Barns, D. A. Pelletier, and D. J. Lane. 1991. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173:697-703. [DOI] [PMC free article] [PubMed] [Google Scholar]